A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.

Autor: Hauser, P., Khosia, J., Aurora, H., Laurin, J., Kling, M.A., Hill, J., Gulati, M., Thornton, A.J., Schultz, R.L., Valentine, A.D., Meyers, C.A., Howell, C.D.
Předmět:
Zdroj: Molecular Psychiatry; 2002, Vol. 7 Issue 9, p942, 6p
Abstrakt: Studies the incidence and open-label anti-depressant treatment of interferon-induced depression in patients with hepatitis C in the U.S. Symptoms of depression during combination therapy with interferon and ribavirin; Efficacy of selective serotonin reuptake inhibitors.
Databáze: Complementary Index